Dr Lee Schwartzberg Outlines Potential Steps To Expand Access Of Novel Therapies In Immuno-Oncology

Dr Lee Schwartzberg Outlines Potential Steps to Expand Access of Novel Therapies in Immuno-Oncology

ASCO24 Direct Highlight | Lee Schwartzberg, MD, FACP

Total Health | Oncology

Dr Lee Schwartzberg Reflects on the Approval of the First Immunotherapy Regimen in Breast Cancer

INspired | Beyond the White Coat with Dr. Lee Schwartzberg

Total Health | Oncology

Dr Lee Schwartzberg Outlines Challenges With Accessing Multigene Testing in the Community Setting

Dr. Lee Schwartzberg on ICLIO and Immuno-Oncology in the Community from ASCO

How to deliver innovative immunotherapies to patients in the 'real world'

ACCC Immuno-Oncology Institute resources help navigate complexities of immunotherapies

Lee Schwartzberg,MD: Targeted Therapies and Clinical Trials in the Community Setting

Vital Options International

2023 Best of Breast Legends Award | Tribute to Lee Schwartzberg, MD, FACP

Total Health | Oncology

Dr Lee Schwartzberg Explains the Promise of Liquid Biopsies in Cancer

Lee Schwartzberg, MD - Hematology Oncology

A Patient’s View of Breast Cancer: The First Meeting

Lee S Schwartzberg MD on Progress of the Institute for Clinical Immuno Oncology

Lee Schwartzberg, MD, on how step therapy & utilization management are impacting community oncology

Expanding the Potential of Immuno-Oncology Therapies

Premier Research

ASCO22 Metastatic Breast Cancer Updates | Lee Schwartzberg, MD | Renown Institute for Cancer

Total Health | Oncology

Lee Schwartzberg, MD, FACP - Cancer as a Chronic Disease

George Clinical

Future Directions in Breast Cancer - A Conversation with Lee Schwartzberg

Dr. Schwartzberg on Emerging Biomarkers in NSCLC